Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study.
Matharu
Manjit S
MS
Headache Group, Institute of Neurology, Queen Square, London, United Kingdom.
Levy
Miles J
MJ
Meeran
Karim
K
Goadsby
Peter J
PJ
D000293:Adolescent; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003027:Cluster Headache / Q000188:drug therapy*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous / Q000379:methods; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010147:Pain Measurement; D013997:Time Factors; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide